600161 天壇生物
按盤價 
13.390 +0.140 (+1.057%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 1.067 | 9.538 | 14.781 | 11.923 | 10.458 |
| 總資產報酬率 ROA (%) | 0.757 | 6.723 | 10.308 | 8.186 | 7.189 |
| 投入資產回報率 ROIC (%) | 1.035 | 9.238 | 14.192 | 11.165 | 9.613 | 邊際利潤分析 |
| 銷售毛利率 (%) | 34.591 | 43.852 | 54.700 | 50.762 | 49.076 |
| 營業利潤率 (%) | 19.566 | 29.788 | 42.405 | 34.842 | 33.607 |
| 息稅前利潤/營業總收入 (%) | 19.584 | 29.518 | 41.684 | 33.763 | 32.109 |
| 淨利潤/營業總收入 (%) | 15.686 | 24.155 | 35.018 | 29.138 | 28.270 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 86.221 | 101.635 | 98.703 | 97.336 | 94.969 |
| 價值變動淨收益/利潤總額(%) | 2.473 | 1.480 | 2.510 | 2.069 | 1.972 |
| 營業外收支淨額/利潤總額(%) | -0.077 | -0.800 | -0.415 | -0.356 | -0.410 | 償債能力分析 |
| 流動比率 (X) | 8.818 | 7.995 | 6.893 | 5.915 | 6.282 |
| 速動比率 (X) | 4.439 | 4.108 | 3.439 | 3.692 | 4.267 |
| 資產負債率 (%) | 7.067 | 7.639 | 8.421 | 10.105 | 12.171 |
| 帶息債務/全部投入資本 (%) | 0.795 | 1.429 | 1.048 | 3.661 | 5.967 |
| 股東權益/帶息債務 (%) | 12,237.485 | 6,761.790 | 9,261.163 | 2,590.586 | 1,547.292 |
| 股東權益/負債合計 (%) | 1,006.622 | 926.385 | 833.533 | 685.127 | 558.916 |
| 利息保障倍數 (X) | 604.031 | -883.420 | -76.390 | -35.317 | -23.595 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 107.580 | 46.380 | 6.591 | 1.777 | 1.820 |
| 存貨周轉天數 (天) | 492.301 | 410.141 | 442.258 | 365.297 | 371.289 |
| 備註： | 即時報價更新時間為 25/05/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
